BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16008004)

  • 41. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COPD guidelines: the important thing is not to stop questioning.
    Fabbri LM; Boschetto P; Mapp CE; ;
    Am J Respir Crit Care Med; 2007 Sep; 176(6):527-8. PubMed ID: 17823358
    [No Abstract]   [Full Text] [Related]  

  • 46. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination therapy with maintenance budesonide and formoterol in COPD.
    Medford AR
    Eur Respir J; 2004 Dec; 24(6):1070; author reply 1070-1. PubMed ID: 15572556
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
    Ernst P; Franssen E; Chan CK; Okell M; O'Byrne P; Bai T
    Respir Med; 2008 Jan; 102(1):77-81. PubMed ID: 17904834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-acting beta 2-agonists in addition to inhaled corticosteroids in children and adults with chronic asthma. A survey of two Cochrane reviews].
    Ulrik CS
    Ugeskr Laeger; 2007 Mar; 169(11):997-1001. PubMed ID: 17371632
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhalation of corticosteroid and β-agonist for persistent cough following pulmonary resection.
    Sawada S; Suehisa H; Yamashita M
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):285-8. PubMed ID: 22453538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 54. [Inhaled therapy via nebulization: practical issues].
    Antoniu S; Bararu T; Zizilaş G; Mihăescu T
    Pneumologia; 2007; 56(3):143-6. PubMed ID: 18019975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-acting beta 2-stimulants].
    Tamura G
    Nihon Rinsho; 2001 Oct; 59(10):1973-8. PubMed ID: 11676141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma].
    Bjerre JV; Bender L; Naeraa RW; Rix M
    Ugeskr Laeger; 2008 Jun; 170(24):2161. PubMed ID: 18565305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-acting beta-agonists and exercise.
    Weinberger M
    J Allergy Clin Immunol; 2008 Aug; 122(2):251-3. PubMed ID: 18582922
    [No Abstract]   [Full Text] [Related]  

  • 58. Can low-dose combination products for inhalation be formulated in single crystalline particles?
    Kumon M; Kwok PC; Adi H; Heng D; Chan HK
    Eur J Pharm Sci; 2010 Apr; 40(1):16-24. PubMed ID: 20172026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pragmatic approach to simplify inhaler therapy for COPD.
    Lipworth B; Jabbal S
    Lancet Respir Med; 2017 Sep; 5(9):679-681. PubMed ID: 28693987
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhaled corticosteroids in severe COPD.
    Bousquet J
    Lancet Respir Med; 2013 May; 1(3):177-8. PubMed ID: 24429112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.